Health News Releases

  • Today May 20
November 14, 2016 17:05
New landmark study reveals adults with diabetes at unnecessary risk of vision loss
Despite vision loss being feared twice as much as other common complications of diabetes (including cardiovascular disease and stroke) a quarter of people with diabetes surveyed are not discussing eye
November 14, 2016 14:20
Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device for High-Burden Settings
Masimo (NASDAQ: MASI) announced today, in advance of World Pneumonia Day tomorrow, that it has received a grant of $4.95 million from the Bill & Melinda Gates Foundation (BMGF). The grant will support
November 14, 2016 11:30
Patient enrolment completed for RE-DUAL PCI™ study assessing dabigatran in atrial fibrillation patients after PCI with stenting
Patient enrolment into the international Phase IIIb RE-DUAL PCI™ study is complete.[1] The study evaluates the safety and efficacy of dabigatran etexilate (marketed as Pradaxa®) in atrial fibrillation
November 09, 2016 15:50
Adare Pharmaceuticals Appoints Dr. Peter Richardson as Vice President, Research & Development and Chief Medical Officer
Adare Pharmaceuticals, Inc. announced that Dr. Peter Richardson has joined the Company as Vice President, Research & Development and Chief Medical Officer. Dr. Richardson will be responsible for leadi
November 09, 2016 15:10
Bioventus Appoints Andrew McCartney Managing Director, International for EMEA
Bioventus, a global leader in orthobiologic solutions, today announced the appointment of Andrew McCartney as Managing Director, International for Europe, Middle East and Africa (EMEA). McCartney, who
November 09, 2016 11:20
Seattle Genetics and Takeda Complete Enrollment of Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline Mature T-cell Lymphoma
Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced completion of patient enrollment in the ECHELON-2 clinical trial. ECHELON-2 is a global phase
November 08, 2016 18:15
New European study highlights differing priorities in physician’s therapy goals when treating advanced lung cancer patients
Results from a survey analysing the prescribing behaviour of 500 European physicians treating patients with advanced non-small cell lung cancer (NSCLC) have been published in Clinical Lung Cancer. The
November 08, 2016 14:20
Philips and Masimo Sign Multi-Year Business Partnership Agreement in Patient Monitoring and Select Therapy Solutions
Royal Philips (NYSE: PHG; AEX: PHIA) and Masimo Corporation (NASDAQ: MASI) today announced a wide-ranging, multi-year business partnership involving both companies’ innovations in patient monitoring a
November 07, 2016 11:20
New Children’s Health Products Sell Out at Mannatech’s Asia MannaFest℠ 2016 Event
Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to changing lives to make a better world, sold out its pre-order of two newly launched children’s health product
November 04, 2016 10:15
Takeda to Present Broad Range of Clinical Data During 58th American Society of Hematology Annual Meeting
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will present a total of 16 company-sponsored abstracts at the 58th American Society of Hematology (ASH) Annual Meeting taking
November 03, 2016 17:05
Medtronic Signs the “Open Data Pledge” to Share Data to Improve Patient Safety
The Patient Safety Movement Foundation (PSMF) today announced that Medtronic, a leading global healthcare solutions company, has joined a growing list of healthcare technology companies that have sign
November 02, 2016 18:00
Takeda Donates 1 Billion Yen as an Exclusive Partner to the United Nations Foundation for “Global Measles Vaccination for Children” Program
Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced that Takeda will exclusively support “Global Measles Vaccination for Children” by the United Nations Foundation’s Shot@Life campaign.
November 02, 2016 17:45
Takeda: CSR Programs Focusing on Maternal and Child Health
Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced that the company will implement three CSR programs focusing on solutions to maternal and child healthcare problems in Africa and Asia
November 02, 2016 11:05
Overall survival data from LUX-Lung 7 head-to-head trial of afatinib versus gefitinib presented at ESMO 2016
Boehringer Ingelheim today announced results from the LUX-Lung 7 trial that directly compared the efficacy and safety of second-generation EGFR-directed therapy afatinib* (Giotrif®) and first-generati
October 31, 2016 10:25
Takeda Reports First Half FY2016 Results and Raises Full Year Profit Guidance
Takeda Pharmaceutical Company Limited (TOKYO:4502): Strong first half results led by Growth Drivers · Underlying Revenue grew +7.4%, led by a +15.3% increase of Takeda's Growth Drivers (GI, Onc
October 29, 2016 03:00
Face the Facts: Stroke is Treatable
Every two seconds, someone in the world is having a stroke. Globally, stroke is the leading cause of disability and the second leading cause of death. The right stroke care can save lives, but glob
October 27, 2016 11:15
Boehringer Ingelheim’s adalimumab biosimilar candidate shows similar efficacy and safety profile to Humira® in pivotal Phase III study
Boehringer Ingelheim today announced top-line results from the pivotal Phase III clinical study of BI 695501, a biosimilar candidate to U.S.-licensed Humira® and EU approved Humira® (adalimumab). BI 6
October 25, 2016 13:30
Q2 Solutions Enhances Companion Diagnostics Capabilities in Collaboration with Illumina
Q2 Solutions, a global clinical trials laboratory services organization, today announced the expansion of its genomic companion diagnostics (CDx) capabilities. This comes as a result of an agreement b
October 19, 2016 17:55
World Federation of Societies of Anaesthesiologists (WFSA) Signs Commitment to Support Patient Safety Movement’s Mission of Zero Patient Deaths by 2020
The World Federation of Societies of Anaesthesiologists (WFSA) has signed a commitment to action and announced that it will support the Patient Safety Movement Foundation (PSMF) and its mission to eli
October 19, 2016 13:50
QuintilesIMS Wins Society for Clinical Research Sites’ 2016 Eagle Award
QuintilesIMS (NYSE:Q) announced today that it has been awarded the 2016 Eagle Award from the Society for Clinical Research Sites (SCRS) for the fourth consecutive year. Presented during the annual SCR
October 19, 2016 10:05
Takeda Showcases Continued Commitment in Hodgkin Lymphoma During 10th International Symposium on Hodgkin Lymphoma (ISHL)
Takeda Pharmaceutical Company Limited (TSE: 4502) will present data on ADCETRIS® (brentuximab vedotin) in Hodgkin lymphoma at the 10th International Symposium on Hodgkin Lymphoma (ISHL), October 22 -
October 17, 2016 11:15
Oral GED-0301 Phase 1b Results Show Clinical Remission and Endoscopic Response at Week 12 in Patients with Active Crohn’s Disease
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that data from a randomized, double-blind, multicenter, exploratory phase 1b study evaluati
October 14, 2016 17:55
QuintilesIMS Named 2016 Frost & Sullivan Asia Pacific CRO Company of the Year
QuintilesIMS today was named Asia Pacific Contract Research Organization (CRO) Company of the Year by Frost & Sullivan, a leading business research and consulting firm, because of its industry leaders
October 14, 2016 11:20
Celgene to Present New Data on Investigational Compounds at UEGW and ACG Congresses
Celgene Corporation (NASDAQ:CELG) today announced that findings from clinical trials of investigational compounds GED-0301 (mongersen), ozanimod and RPC4046 will be presented at the United European Ga
October 12, 2016 10:00
Mannatech’s Asia MannaFest℠ Event Fuels Company Momentum
Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, is hosting its annual Asia MannaFest event at Olympic Park Handbal
25 per page50 per page75 per page100 per page